BACKGROUND: Proinflammatory cytokines such as tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6) are important mediators of immune response, associated with endothelial dysfunction in patients with coronary artery disease (CAD) or heart failure. We compared endothelial function and levels of IL-6 and TNF-alpha between patients with ischemic heart failure, dilated cardiomyopathy, CAD and healthy controls. METHODS: The population consisted of 20 patients with dilated cardiomyopathy, 48 patients with ischemic cardiomyopathy, 26 patients with CAD and normal left ventricle function and 14 healthy controls. Forearm blood flow was measured using venous occlusion strain gauge plethysmography. Forearm vasodilatory response to reactive hyperemia (RH%) or to nitrate were considered as indexes of endothelium-dependent and endothelium-independent dilation, respectively. RESULTS: Levels of IL-6 were significantly higher in ischemic cardiomyopathy compared to CAD patients (P<0.05) or controls (P<0.05) and in patients with dilated cardiomyopathy compared to controls (P<0.05). TNF-alpha levels were significantly higher in both groups with ischemic or dilated cardiomyopathy compared to CAD (P<0.05) or controls (P<0.05). RH% was significantly lower in ischemic and dilated cardiomyopathy compared to CAD (P<0.05) or controls (P<0.001) and higher in dilated than ischemic cardiomyopathy (P<0.05). CONCLUSIONS: Impaired endothelial function and increased inflammatory process were found in both types of heart failure. A greater endothelial dysfunction was observed in patients with ischemic heart failure compared to those with dilated cardiomyopathy, implying that the underlying atherosclerosis may participate in this process.
BACKGROUND: Proinflammatory cytokines such as tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6) are important mediators of immune response, associated with endothelial dysfunction in patients with coronary artery disease (CAD) or heart failure. We compared endothelial function and levels of IL-6 and TNF-alpha between patients with ischemic heart failure, dilated cardiomyopathy, CAD and healthy controls. METHODS: The population consisted of 20 patients with dilated cardiomyopathy, 48 patients with ischemic cardiomyopathy, 26 patients with CAD and normal left ventricle function and 14 healthy controls. Forearm blood flow was measured using venous occlusion strain gauge plethysmography. Forearm vasodilatory response to reactive hyperemia (RH%) or to nitrate were considered as indexes of endothelium-dependent and endothelium-independent dilation, respectively. RESULTS: Levels of IL-6 were significantly higher in ischemic cardiomyopathy compared to CAD patients (P<0.05) or controls (P<0.05) and in patients with dilated cardiomyopathy compared to controls (P<0.05). TNF-alpha levels were significantly higher in both groups with ischemic or dilated cardiomyopathy compared to CAD (P<0.05) or controls (P<0.05). RH% was significantly lower in ischemic and dilated cardiomyopathy compared to CAD (P<0.05) or controls (P<0.001) and higher in dilated than ischemic cardiomyopathy (P<0.05). CONCLUSIONS: Impaired endothelial function and increased inflammatory process were found in both types of heart failure. A greater endothelial dysfunction was observed in patients with ischemic heart failure compared to those with dilated cardiomyopathy, implying that the underlying atherosclerosis may participate in this process.
Authors: Ronald A Cohen; Athena Poppas; Daniel E Forman; Karin F Hoth; Andreana P Haley; John Gunstad; Angela L Jefferson; David F Tate; Robert H Paul; Lawrence H Sweet; Mokato Ono; Beth A Jerskey; Marie Gerhard-Herman Journal: J Clin Exp Neuropsychol Date: 2008-06-16 Impact factor: 2.475
Authors: Michael Bestawros; Takondwa Chidumayo; Meridith Blevins; Ashley Canipe; Jay Bala; Paul Kelly; Suzanne Filteau; Bryan E Shepherd; Douglas C Heimburger; John R Koethe Journal: J AIDS Clin Res Date: 2015-03
Authors: Zaid O Ibraheem; Munavvar A Sattar; Nor A Abdullah; Hassaan A Rathore; Edward J Johns Journal: Bosn J Basic Med Sci Date: 2012-02 Impact factor: 3.363
Authors: Costantino Caroselli; Rosario De Rosa; Pietro Tanzi; Alberto Rigatelli; Guglielmo Bruno Journal: Int J Immunopathol Pharmacol Date: 2015-12-18 Impact factor: 3.219
Authors: Marco Matteo Ciccone; Massimo Iacoviello; Agata Puzzovivo; Pietro Scicchitano; Francesco Monitillo; Francesco De Crescenzo; Vito Caragnano; Marco Sassara; Giovanni Quistelli; Pietro Guida; Stefano Favale Journal: Clin Res Cardiol Date: 2011-01-07 Impact factor: 5.460
Authors: Sohail Malek; Emel Kaplan; Ju-Feng Wang; Qingen Ke; Jamal S Rana; Yu Chen; Bilal G Rahim; Ma Li; Qin Huang; Yong-Fu Xiao; Freek W A Verheugt; James P Morgan; Jiang-Yong Min Journal: Pflugers Arch Date: 2006-01-26 Impact factor: 3.657